DCC awarded $24M MU data contract

The Centers for Medicare & Medicaid Services (CMS) has awarded a contract to Data Computer Corporation of America (DCCA), a veteran-owned information technology services company, to provide support to the National Level Repository (NLR), which serves as the central system in the Meaningful Use program. The contract has a value of $24 million if all options are exercised.

"The HITECH Act is an important piece of legislation to help drive the adoption of electronic health records (EHR)," said DCCA CEO David W. Bower in a release. "We have significant past performance in enabling CMS to maintain continuity and increase the focus on software quality and reliability, and look forward to continuing that support."

DCCA's focus will be to work with CMS and other HITECH/NLR contractors in maintaining and improving the quality of the program. The centralized location to store information on healthcare organizations participating in Meaningful Use, the NLR has been developed and managed by a number of different vendors since its inception in 2010. The data repository enables CMS to deliver incentive payments and track upcoming negative payment adjustments.

"Keeping the HITECH/NLR program running efficiently and effectively is our number-one priority," said Bower. "The ability to advance the adoption of EHRs is an important improvement for CMS as an agency as well as the citizens it serves."

DCCA will partner with CMS and other infrastructure vendors to maintain and improve the services related to the big data repository’s role in EHR adoption and incentive payments.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.